ATE363473T1 - Substituierte pyrazoloverbindungen zur behandlung von entzündungen - Google Patents
Substituierte pyrazoloverbindungen zur behandlung von entzündungenInfo
- Publication number
- ATE363473T1 ATE363473T1 AT02763656T AT02763656T ATE363473T1 AT E363473 T1 ATE363473 T1 AT E363473T1 AT 02763656 T AT02763656 T AT 02763656T AT 02763656 T AT02763656 T AT 02763656T AT E363473 T1 ATE363473 T1 AT E363473T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- sup
- inflammation
- compounds
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32329701P | 2001-09-19 | 2001-09-19 | |
| US38322602P | 2002-05-24 | 2002-05-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE363473T1 true ATE363473T1 (de) | 2007-06-15 |
Family
ID=26983875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02763656T ATE363473T1 (de) | 2001-09-19 | 2002-09-19 | Substituierte pyrazoloverbindungen zur behandlung von entzündungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7211597B2 (de) |
| EP (1) | EP1427706B1 (de) |
| JP (1) | JP2005510466A (de) |
| AT (1) | ATE363473T1 (de) |
| BR (1) | BR0212617A (de) |
| CA (1) | CA2460939C (de) |
| DE (1) | DE60220422T2 (de) |
| ES (1) | ES2286275T3 (de) |
| MX (1) | MXPA04002682A (de) |
| WO (1) | WO2003024936A1 (de) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10229762A1 (de) | 2002-07-03 | 2004-01-22 | Aventis Pharma Deutschland Gmbh | Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase |
| WO2004041285A1 (en) | 2002-10-31 | 2004-05-21 | Amgen Inc. | Antiinflammation agents |
| BRPI0409263A (pt) * | 2003-04-09 | 2006-03-28 | Millennium Pharm Inc | composto; composição farmacêutica; método para tratar uma doença mediada por ikk e método para inibir ikk em um paciente que dele necessita |
| US7132428B2 (en) | 2003-07-03 | 2006-11-07 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders |
| EP1644371B1 (de) * | 2003-07-03 | 2008-02-13 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinolinenderivaten als kinase inhibitoren |
| EP1694686A1 (de) * | 2003-12-19 | 2006-08-30 | Takeda San Diego, Inc. | Kinaseinhibitoren |
| BRPI0509660A (pt) | 2004-04-09 | 2007-10-09 | Millennium Pharm Inc | compostos de beta-carbolina de utilidade no tratamento de doenças inflamatórias |
| US20050250829A1 (en) * | 2004-04-23 | 2005-11-10 | Takeda San Diego, Inc. | Kinase inhibitors |
| AR050253A1 (es) | 2004-06-24 | 2006-10-11 | Smithkline Beecham Corp | Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento |
| WO2006023931A2 (en) * | 2004-08-18 | 2006-03-02 | Takeda San Diego, Inc. | Kinase inhibitors |
| ATE486878T1 (de) * | 2004-08-18 | 2010-11-15 | 4Sc Ag | Benzothienopyridine zur verwendung als inhibitoren von eg5-kinesin |
| PE20060748A1 (es) | 2004-09-21 | 2006-10-01 | Smithkline Beecham Corp | Derivados de indolcarboxamida como inhibidores de quinasa ikk2 |
| EP1812439B2 (de) * | 2004-10-15 | 2017-12-06 | Takeda Pharmaceutical Company Limited | Kinaseinhibitoren |
| WO2006079645A1 (en) * | 2005-01-27 | 2006-08-03 | Nycomed Gmbh | Novel indolopyridines , benzofuranopyridines and benzothienopyridines |
| JP2008528551A (ja) * | 2005-01-28 | 2008-07-31 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | インドロピリジン、ベンゾフラノピリジン及びベンゾチエノピリジン |
| ES2370419T3 (es) * | 2005-06-23 | 2011-12-15 | Merck Sharp & Dohme Corp. | Inhibidores de tirosina quinasa. |
| TW200738638A (en) * | 2005-06-23 | 2007-10-16 | Merck & Co Inc | Tyrosine kinase inhibitors |
| WO2007002254A2 (en) | 2005-06-23 | 2007-01-04 | Merck & Co., Inc. | Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| AR055343A1 (es) | 2005-06-30 | 2007-08-22 | Smithkline Beecham Corp | Derivados de indolcarboxamida inhibidores de quinasas ikk2 |
| US8119655B2 (en) * | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| CA2624656A1 (en) * | 2005-10-21 | 2007-05-03 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| WO2007050380A2 (en) * | 2005-10-21 | 2007-05-03 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| EA015151B1 (ru) * | 2006-02-22 | 2011-06-30 | 4ЭсЦэ АГ | Индолопиридины в качестве модуляторов кинезина eg5 |
| KR101415354B1 (ko) * | 2006-02-22 | 2014-07-04 | 4에스체 악티엔게젤샤프트 | Ｅｇ5 키네신 조절제로서의 인돌로피리딘 |
| TW200813054A (en) * | 2006-06-02 | 2008-03-16 | Elan Pharm Inc | Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| TW200813021A (en) * | 2006-07-10 | 2008-03-16 | Merck & Co Inc | Tyrosine kinase inhibitors |
| JP2009542777A (ja) * | 2006-07-13 | 2009-12-03 | ４エスツェー アクチェンゲゼルシャフト | ベンゾピラノピラゾール |
| SG158147A1 (en) | 2006-10-09 | 2010-01-29 | Takeda Pharmaceutical | Kinase inhibitors |
| EP2223925A1 (de) * | 2006-10-09 | 2010-09-01 | Takeda Pharmaceutical Company Limited | Kinase-Inhibitoren |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| EP2278999B1 (de) | 2008-04-21 | 2025-01-29 | Dompé farmaceutici S.p.A. | Ohrbehandlungsformulierungen zur behandlung von ohrenerkrankungen und -leiden |
| US20110212053A1 (en) * | 2008-06-19 | 2011-09-01 | Dapeng Qian | Phosphatidylinositol 3 kinase inhibitors |
| JP2012506848A (ja) * | 2008-10-27 | 2012-03-22 | グラクソ グループ リミテッド | グルタミン酸受容体モジュレーターとしての三環式化合物 |
| WO2010102968A1 (en) | 2009-03-10 | 2010-09-16 | Glaxo Group Limited | Indole derivatives as ikk2 inhibitors |
| WO2014055624A1 (en) | 2012-10-02 | 2014-04-10 | The General Hospital Corporation D/B/A Massachusetts General Hospital | Methods relating to dna-sensing pathway related conditions |
| KR102318498B1 (ko) * | 2013-06-24 | 2021-10-27 | 메르크 파텐트 게엠베하 | Fshr의 조절인자로서의 피라졸 화합물 및 이의 용도 |
| WO2015196335A1 (en) * | 2014-06-23 | 2015-12-30 | Tocopherx, Inc. | Pyrazole compounds as modulators of fshr and uses thereof |
| AU2017290256A1 (en) | 2016-06-29 | 2019-01-17 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
| CN110914277B (zh) * | 2017-07-10 | 2022-08-09 | 上海瑛派药业有限公司 | 咪唑并[1,2-b]嘧啶并[4,5-d]哒嗪-5(6H)-酮类化合物及其应用 |
| JP2025527759A (ja) * | 2022-08-26 | 2025-08-22 | セルマティクス インク． | Ｆｓｈｒの新規なモジュレータおよびその使用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3940418A (en) * | 1972-04-07 | 1976-02-24 | G. D. Searle & Co. | Esters and amides of 4,5-dihydrobenz[g]indazole-3-carboxylic acids and related compounds |
| US4678499A (en) * | 1985-03-11 | 1987-07-07 | E. I. Du Pont De Nemours And Company | Herbicidal sulfonamides |
| JPS63166588A (ja) * | 1986-12-27 | 1988-07-09 | Kanzaki Paper Mfg Co Ltd | クロメノ化合物およびクロメノ化合物を用いた感熱記録体 |
| US4816467A (en) * | 1987-01-09 | 1989-03-28 | Farmitalia Carlo Erba S.R.L | Heteroaryl 3-oxo-propanenitrile derivatives, pharmaceutical compositions and use |
| GB8814587D0 (en) | 1988-06-20 | 1988-07-27 | Erba Carlo Spa | Condensed pyrazole 3-oxo-propanenitrile derivatives & process for their preparation |
| GB2227741B (en) | 1989-02-06 | 1992-08-05 | Erba Carlo Spa | Condensed 3-oxo-propanenitrile derivatives and process for their preparation |
| US5260328A (en) * | 1989-04-06 | 1993-11-09 | Farmitalia Carlo Erba Srl | Phenyl-indenopurazol 3-oxo-propanamide derivatives useful in the treatment of rheumatoid arthritis |
| GB8907799D0 (en) * | 1989-04-06 | 1989-05-17 | Erba Carlo Spa | Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases |
| GB8916290D0 (en) * | 1989-07-17 | 1989-08-31 | Erba Carlo Spa | Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| US5696143A (en) | 1994-09-20 | 1997-12-09 | Talley; John J. | Benz G! indazolyl derivatives for the treatment of inflammation |
| US5547975A (en) * | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| US5886016A (en) * | 1995-09-15 | 1999-03-23 | G.D. Searle & Co. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| US5756529A (en) * | 1995-09-29 | 1998-05-26 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies |
| ATE233743T1 (de) | 1996-04-12 | 2003-03-15 | Searle & Co | N-((4-(5-methyl-3-phenylisoxazol-4- yl)phenyl)sulphonylpropylamid und sein natriumsalz als pro-pharmakon von cox-2 inhibitoren |
| CN1311678A (zh) | 1998-04-30 | 2001-09-05 | 巴斯福股份公司 | 具有蛋白激酶活性的取代的三环吡唑衍生物 |
| EP1142889A1 (de) | 2000-04-03 | 2001-10-10 | Pfizer Products Inc. | Pyrazolderivate als entzündungs-/schmerzhemmende Mittel |
-
2002
- 2002-09-19 AT AT02763656T patent/ATE363473T1/de not_active IP Right Cessation
- 2002-09-19 MX MXPA04002682A patent/MXPA04002682A/es active IP Right Grant
- 2002-09-19 JP JP2003528784A patent/JP2005510466A/ja active Pending
- 2002-09-19 DE DE60220422T patent/DE60220422T2/de not_active Expired - Fee Related
- 2002-09-19 CA CA002460939A patent/CA2460939C/en not_active Expired - Fee Related
- 2002-09-19 US US10/247,028 patent/US7211597B2/en not_active Expired - Fee Related
- 2002-09-19 BR BR0212617-6A patent/BR0212617A/pt not_active IP Right Cessation
- 2002-09-19 WO PCT/US2002/029625 patent/WO2003024936A1/en not_active Ceased
- 2002-09-19 EP EP02763656A patent/EP1427706B1/de not_active Expired - Lifetime
- 2002-09-19 ES ES02763656T patent/ES2286275T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US7211597B2 (en) | 2007-05-01 |
| WO2003024936A1 (en) | 2003-03-27 |
| DE60220422D1 (de) | 2007-07-12 |
| ES2286275T3 (es) | 2007-12-01 |
| MXPA04002682A (es) | 2004-06-18 |
| JP2005510466A (ja) | 2005-04-21 |
| EP1427706A1 (de) | 2004-06-16 |
| US20030114432A1 (en) | 2003-06-19 |
| CA2460939C (en) | 2008-07-29 |
| DE60220422T2 (de) | 2008-02-07 |
| CA2460939A1 (en) | 2003-03-27 |
| BR0212617A (pt) | 2005-02-09 |
| EP1427706B1 (de) | 2007-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE363473T1 (de) | Substituierte pyrazoloverbindungen zur behandlung von entzündungen | |
| EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| DE60219793D1 (de) | Methode zur behandlung von zytokinvermittelten erkrankungen | |
| ATE311386T1 (de) | Verfahren zur herstellung von 1,5,6,7- tetrahydropyrrolo(3,2-c)derivaten zur behandlung der fettleibigkeit | |
| MXPA04000622A (es) | Pirazolilcarboxanilidas como funguicidas. | |
| ATE343388T1 (de) | Pde-v hemmer zur behandlung von morbus parkinson | |
| DK1353672T3 (da) | Syntese af 4-amino-thalidomidenantiomerer | |
| MXPA04002070A (es) | Compuestos de indazol sustituidos para el tratamiento de la inflamacion. | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
| MY141011A (en) | Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones | |
| ATE432930T1 (de) | Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen | |
| ATE363474T1 (de) | Benzimidazole zur behandlung sexueller fehlfunktionen | |
| ATE432278T1 (de) | Verbindungen zur behandlung von krankheiten | |
| ATE367380T1 (de) | Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate | |
| DE602004021363D1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
| GEP20053590B (en) | Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors | |
| ATE179168T1 (de) | Substituierte spiroverbindungen zur behandlung von entzündungen | |
| MXPA05004845A (es) | N-oxidos y derivados de melfalan para el tratamiento de estados de enfermedad asociados a un factor inducible por hipoxia. | |
| ATE346040T1 (de) | Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit | |
| DE60226971D1 (de) | Corticotropinfreisetzungsfaktor antagonisten | |
| MXPA04005151A (es) | Compuestos terapeuticos. | |
| CA2485298A1 (en) | Substituted pyrazolyl compounds for the treatment of inflammation | |
| ATE315387T1 (de) | Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |